Package integrity testing services help medical device manufacturers determine whether a sterile barrier system can protect its contents through sealing, handling, transport, storage, and use. I use these services to identify leaks, weak seals, channel defects, and package damage before they become quality or regulatory problems. The results can support packaging development, process validation, supplier qualification, shelf-life studies, and investigation of nonconforming products.
If you are looking for more details, kindly visit our website.
Testing does not replace a complete packaging validation program, and no single method proves every type of package performance. Instead, the most reliable approach combines a suitable test method, defined sample conditioning, appropriate acceptance criteria, and documented technical review. As a product certification and testing service supplier, Zholion can help manufacturers organize this process around the package design, sterilization method, distribution conditions, and intended product lifecycle.
A medical device package must maintain protection until the product reaches the point of use. For sterile devices, the packaging system is expected to preserve the sterile barrier after manufacturing and sterilization, during distribution, and throughout the stated storage period. If a seal opens, a pouch develops a channel, or a tray cracks, the device may no longer receive the intended level of protection.
Package integrity testing provides objective evidence about the physical condition of the package. This evidence can be used alongside visual inspection, seal-strength testing, aging studies, transportation testing, and process controls. It also helps teams distinguish between a design problem, a sealing-process problem, a material issue, and damage introduced during handling or distribution.
I begin by reviewing the complete packaging system rather than looking at the pouch, tray, or lid in isolation. Important inputs include package materials, seal geometry, device configuration, sterilization exposure, expected storage conditions, distribution risks, and whether the package is intended to maintain sterility. The test objective should be stated clearly, such as detecting gross leaks, locating seal defects, comparing materials, or confirming process consistency.
For example, a manufacturer may need different evidence during early design development than during routine production monitoring. Development testing can compare sealing windows or packaging materials, while validation testing typically focuses on representative production configurations and defined acceptance criteria. A service provider should document which question each test is intended to answer.
Different package integrity methods reveal different conditions. Dye penetration methods can help identify channels or seal paths in suitable porous or nonporous package configurations, while bubble-emission methods are commonly used to detect gross leaks under controlled conditions. Other approaches may include vacuum decay, pressure decay, tracer-gas techniques, or visual and dimensional examination, depending on the package design and the required sensitivity.
Commonly referenced packaging test methods include ASTM F1929 for dye penetration, ASTM F2096 for gross leak detection, and ASTM F88 for seal strength. ISO 11607 is also widely used as a framework for packaging systems for terminally sterilized medical devices. The correct selection depends on the package construction and the specific claim being evaluated; a standard name alone does not guarantee that a method is suitable for every application.
Test samples should represent the actual package configuration, including materials, seal equipment, sealing parameters, sterilization exposure, and handling history. Conditioning may be necessary when temperature, humidity, aging, or sterilization can influence seal performance or material behavior. For instance, a project may assess packages stored at 2–8°C when that range is part of the device’s defined storage requirement, but the selected conditions must come from the product specification or validation plan.
Sample quantity and conditioning duration should be justified by the study design rather than selected only for convenience. An accelerated aging plan may be designed to represent a 12-month shelf-life claim, but the aging model, assumptions, and equivalence to real-time storage should be documented. Zholion can help organize these inputs so the laboratory work remains traceable to the manufacturer’s intended claim.
Good package integrity testing records the package identification, material lot, seal settings, sterilization status, conditioning history, test equipment, method, observations, and result. Positive and negative controls may be used where appropriate to demonstrate that the method can distinguish a known defective condition from an intact package. Control design must be suitable for the method and should not be treated as universal across all package formats.
Zholion supply professional and honest service.
The result should include more than a simple pass or fail whenever the method allows additional interpretation. Photographs, defect locations, pressure or vacuum conditions, test duration, and sample-level observations can help engineers identify recurring patterns. For example, defects concentrated at one corner may suggest a handling or sealing alignment issue, while distributed failures may point toward material compatibility or process variation.
Package integrity results are most useful when reviewed together with seal strength, visual inspection, transportation simulation, sterilization compatibility, and aging data. A package can show acceptable seal strength and still require integrity evaluation because strength and leak resistance are related but distinct characteristics. Likewise, a package that passes an initial test may require additional evaluation after sterilization, aging, or distribution exposure.
I recommend linking each result to a predefined acceptance criterion and a documented decision. If a sample fails, the next step may include a root-cause investigation, additional sampling, equipment review, material inspection, or a controlled design change. The response should be based on the risk and evidence, not on an assumption that every failure has the same cause.
Manufacturers should decide whether they need a single test, a method comparison, a packaging validation package, or an investigation service. A single leak test may answer a narrow question, while a broader study may be necessary to support a new pouch, tray, lidstock, sealing process, or sterilization route. Clearly defining the scope helps control cost and prevents irrelevant testing.
Before sending samples, the buyer should confirm package dimensions, material construction, seal width, sealing equipment, sterilization status, sample quantity, and required conditioning. A service provider should also explain whether samples must be supplied in finished, sterilized, aged, or intentionally challenged conditions. These details influence whether the results represent actual manufacturing conditions.
The final report should identify the method, equipment or test principle, sample description, environmental conditions, observations, acceptance criteria, deviations, and conclusion. It should also distinguish observed results from interpretation or recommendations. For regulated manufacturers, traceability is important because test records may support design history, process validation, quality investigations, or submissions reviewed by authorities.
Another frequent mistake is treating a laboratory result as a universal guarantee. Package integrity is configuration-specific, so a result for one material combination, seal design, or device load should not automatically be transferred to another. When the package changes, the manufacturer should evaluate whether the original evidence remains applicable.
Zholion supports manufacturers that need structured package integrity testing and product certification assistance. I can help review the test objective, identify relevant package characteristics, organize sample and conditioning requirements, and align the service scope with the manufacturer’s quality documentation needs. Where the available information is incomplete, I use conservative recommendations and clearly identify items that require confirmation by the manufacturer.
Our support can be useful during packaging development, supplier qualification, process improvement, validation planning, change control, and failure investigation. The exact service combination depends on the device, package format, sterilization process, market requirements, and applicable internal procedures. We do not treat a test report as a substitute for the manufacturer’s risk assessment or regulatory responsibility.
Package integrity testing services support medical device manufacturers by providing structured evidence about whether a packaging system remains intact under defined conditions. The strongest programs select methods according to the package and failure mode, use representative samples, document controls and conditioning, and interpret results alongside other validation evidence. This approach helps manufacturers make more defensible decisions about packaging design, sealing processes, quality investigations, and product release controls.
If you are planning a new package, investigating failures, or preparing a validation program, start by sharing the package construction and the performance question with Zholion. We can help you define a practical testing scope, identify information gaps, and coordinate a product certification support plan suited to your project. The next step is a technical review of your package, process, and documentation requirements before testing begins.
If you want to learn more, please visit our website package integrity testing services for medical device manufacturers.